Sohn Catherine A.

Sohn Catherine A. is listed in filings as Director at Altimmune, Inc.. This profile follows SEC Form 4 activity through May 1, 2026, including sale activity and purchase activity. Recent filings connect the profile to Altimmune, Inc. (ALT) and Maze Therapeutics, Inc. (MAZE). The current snapshot covers public activity from Sep 30, 2024 to May 1, 2026. Reported amounts are shown as $137.6K to $216.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.